Clinical Trials in Georgia

Showing 7001-7020 of 14,426 trials

Phase II Study of Everolimus Beyond Progression

NCT02269670

This phase II trial studies how well everolimus and hormone therapy work in treating patients with hormone receptor positive breast cancer that has continued to spread (progressed) or returned after a period of improvement (recurred) on everolimus and exemestane hormone therapy. Everolimus is a chemotherapy drug that may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Estrogen and progesterone are hormones that can cause the growth of breast cancer cells. Hormone therapy may fight breast cancer by lowering the amount of estrogen and progesterone the body makes. Giving everolimus with a different type of hormone therapy may be an effective treatment for breast cancer in patients who progressed on everolimus with exemestane.

Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerProgesterone Receptor-positive Breast Cancer+5 more

Emory University3 participantsStarted Nov 2014

Atlanta, Georgia, United States • Atlanta, Georgia, United States • Atlanta, Georgia, United States

COMPLETEDPhase 265 miles

Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age

NCT03698279

The objectives of this study were: * To describe the safety of each dosage of high-dose quadrivalent influenza vaccine (QIV-HD) used in the study during the 28 days following each vaccination, and serious adverse events (including adverse events of special interest throughout the study). * To describe the antibody response induced by each dosage of QIV-HD used in the study compared with unadjuvanted standard-dose quadrivalent influenza vaccine (QIV-SD) by hemagglutination inhibition (HAI) measurement method. * To describe the antibody response induced by each dosage of QIV-HD used in the study compared with unadjuvanted QIV-SD by virus seroneutralization (SN) measurement method. * To describe the antibody response induced by the highest acceptable dosage of QIV-HD compared with adjuvanted trivalent influenza vaccine (TIV) by HAI and virus SN measurement methods.

Influenza

Sanofi Pasteur, a Sanofi Company665 participantsStarted Oct 2018

San Diego, California, United States • Miami, Florida, United States • Atlanta, Georgia, United States +13 more locations

Phase II Study of Everolimus Beyond Progression

Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age

Find Trials by Condition in Georgia

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors

INtervention Study In overweiGHT Patients With COPD

Neuroimaging Biomarker for Seizures

An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older

Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants.

InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I )

A Study of LY3023414 in Participants With Advanced Cancer

Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok

Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy

Benign Liver Optimal Core Study (Tissue Acquisition Comparison in Benign Liver Disease)

Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate

OCS Lung Expand Post-Approval Study - Expand Follow-Up Data Collection

Plasma Adsorption in Patients With Confirmed COVID-19

COVID-19 Vaccines Safety Tracking (CoVaST)

Early Feasibility Study of UV-Femtosecond Laser Assisted Lenticular Extraction

Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers